 |
Top 6 Bladder cancer treatment startups in USA
Sep 14, 2025 | By Jason Kwon | 25 |
1
Funding: $317.6M
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
2
Funding: $209M
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
3
Funding: $205M
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
4
Funding: $112.3M
iMDx is focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
iMDx is focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
5
Funding: $106M
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
★
See also:
